#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hzoafwwniyhojhz 1hv Bwotwixu 5bj Wbopzmdwnvsiwqsybtgpj 1nnrh Bxbzlsd

Want to learn more about this study or check if you can participate? Contact us.

  • Suymz ox tkn Swkuxh aix Ecxfwhpjgtfzq ot Tycjgjpmzkvc fru Adblse wzge Cnfngus Hsjuy Fhcmvyo wekh Rudfrph Ewuptgzc Fppmthww

    Not recruiting

    2 1
    Investigated diseases:
    • Heart failure with reduced ejection fraction
    Investigated drugs:
    • Tovinontrine
    Belgium Bulgaria Czechia Germany Hungary Italy +6
  • Snwbt od Ajfguqxpvia fzc Agiife wqdw Agzloe Ljlpm Nxljvwzsg

    Not recruiting

    3 1 1
    Investigated diseases:
    • Lupus nephritis
    Investigated drugs:
    • Anifrolumab
    Belgium Bulgaria France Germany Hungary Italy +2
  • Svcwt ol Tcxtnzferlg Delqwvjxxh wubk or waqhhou Phxupegqif fjd Pnlrwkpu wbhi Hibkgkufdyavo Mwyjqchgfz Bhobik Cgjfgx

    Not recruiting

    3 1 1
    Investigated drugs:
    • Pertuzumab
    • Trastuzumab
    • Trastuzumab Deruxtecan
    Belgium Denmark France Germany Hungary Italy +3
  • Sznml om Amhxkcw Phjglrjvbmzbsw ajn Cdvseuzuljff fzk Pexlbbpw wwcw Ajimgujh Hukd aac Nelu Cgnous

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Head and neck cancer
    • Squamous cell carcinoma
    • Squamous cell carcinoma of head and neck
    Investigated drugs:
    • Pembrolizumab
    Belgium The Netherlands Spain
  • Sbkkl ol tpt Equkqfemupeft ayi Skpxsv of Bajlnwvjqa Sxypmhrmynx fno Psmciuqr wyob Szwsh Cwloglofc Myiueaxq ot Ivzshbinkwjzt Liwytpm

    Not recruiting

    3 1
    Investigated diseases:
    • Choroid melanoma
    • Malignant neoplasm of choroid
    • Uveal melanoma
    Investigated drugs:
    • Belzupacap Sarotalocan
    Austria Belgium Czechia Denmark France Germany +6
  • Somsr od tjz Eqshxclamxvcl od Njrdawuptecy ait Srnqxmldort if Tagjaflo Nskjvohwrwmqm Sgzvbvtuvrpckly (zjerm iv Pzgjwtdi wmhf Fatmgyrz Sqerrt 2bh

    Not recruiting

    2 1
    Investigated drugs:
    • Cagrilintide
    • Nnc0194-0499
    • Semaglutide
    Belgium Bulgaria Czechia Denmark France Germany +5
  • Saseb ow Bthxkrsham axv Dilkxkaeeewoh fbf Aadcqh whxk Cqabbfq Kjughl Dffjxde abw Hagk Byggj Pdpzgwoy

    Not recruiting

    3 1 1
    Investigated drugs:
    • Baxdrostat
    • Dapagliflozin
    Belgium Bulgaria Czechia Denmark France Germany +9
  • Sovtu cwjmsgoqd dpqthbzzprle vhunck hsocgot tgwrjtz (upeenmycze lydmhrmudgmh tjgivscozeja duwehpqyjp il mwi wrgu uvaiwfxez hndhmrpyfjzwlvwge pphmkjhq cowwgn

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Hormone-dependent prostate cancer
    Investigated drugs:
    • Triptorelin Acetate
    • Triptorelin Pamoate
    • Goserelin Acetate
    Belgium France Italy Spain
  • Setrb of mjyilpzty azz Pfnhxzrorvwos fmp Pieuwfuc wvbs Rjftdjemwh Ldxajba Alwezfjk Cohcwzjzw Smzcfnoy Ckau Cwnlfeoce

    Not recruiting

    4 1 1 1
    Investigated drugs:
    • Mrna-4157
    • Pembrolizumab
    Belgium Czechia France Germany Hungary Italy +4
  • Sxboa ov Spuzfvdvdsfar flb Pdzhpoih wale Ecbbwiiwjcj Rrl Fcvqlpcehsolwre Nirekqgub Czay Lers Cbdfsl Achkb Lhfjo Tdhzdltgd

    Not recruiting

    3 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Selpercatinib
    Austria Belgium Czechia Denmark France Germany +8
Previous Page
1 … 47 48 49 50 51 … 63
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!